Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Clinical Trial Report: Duration of Metronidazole Therapy in HIV-infected Women with Trichomonas vaginalis: Is More Metronidazole Better?

Literature DB >> 21365373

Clinical Trial Report: Duration of Metronidazole Therapy in HIV-infected Women with Trichomonas vaginalis: Is More Metronidazole Better?

Laura H Bachmann¹.

Abstract

Entities: Chemical Disease Species

Year: 2011 PMID： 21365373 DOI： 10.1007/s11908-010-0161-9

Source DB: PubMed Journal: Curr Infect Dis Rep ISSN： 1523-3847 Impact factor: 3.725

Keyword Cloud
References

× No keyword cloud information.

11 in total

1. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic.

Authors: J L Joyner; J M Douglas; S Ragsdale; M Foster; F N Judson
Journal: Sex Transm Dis Date: 2000-04 Impact factor: 2.830

2. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.

Authors: Ayesha Khan; J Dennis Fortenberry; Beth E Juliar; Wanzhu Tu; Donald P Orr; Byron E Batteiger
Journal: Sex Transm Dis Date: 2005-04 Impact factor: 2.830

3. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.

Authors: D Watson-Jones; K Mugeye; P Mayaud; L Ndeki; J Todd; F Mosha; B West; B Cleophas-Frisch; H Grosskurth; M Laga; R Hayes; D Mabey; A Buvé
Journal: Sex Transm Infect Date: 2000-10 Impact factor: 3.519

4. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

Authors: R Scott McClelland; Laura Sangare; Wisal M Hassan; Ludo Lavreys; Kishorchandra Mandaliya; James Kiarie; Jeckoniah Ndinya-Achola; Walter Jaoko; Jared M Baeten
Journal: J Infect Dis Date: 2007-01-22 Impact factor: 5.226

5. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

Authors:
Journal: MMWR Recomm Rep Date: 2003-07-18

6. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

Authors: Jane R Schwebke; Edward W Hook
Journal: J Infect Dis Date: 2003-07-10 Impact factor: 5.226

Clinical Trial Report: Duration of Metronidazole Therapy in HIV-infected Women with Trichomonas vaginalis: Is More Metronidazole Better?

1. Comparative prevalence of infection with Trichomonas vaginalis among men attending a sexually transmitted diseases clinic.

2. The prevalence of chlamydia, gonorrhea, and trichomonas in sexual partnerships: implications for partner notification and treatment.

3. High prevalence of trichomoniasis in rural men in Mwanza, Tanzania: results from a population based study.

4. Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition.

5. Incorporating HIV prevention into the medical care of persons living with HIV. Recommendations of CDC, the Health Resources and Services Administration, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America.

6. High rates of Trichomonas vaginalis among men attending a sexually transmitted diseases clinic: implications for screening and urethritis management.

7. Early repeated infections with Trichomonas vaginalis among HIV-positive and HIV-negative women.

8. The prevalence of Trichomonas vaginalis infection among reproductive-age women in the United States, 2001-2004.

9. HIV, the clustering of sexually transmitted infections, and sex risk among African American women who use drugs.

10. Trichomonas vaginalis treatment reduces vaginal HIV-1 shedding.